Globus Medical to Acquire Nevro Corp. to Expand Treatment …
AUDUBON, Pa. and REDWOOD CITY, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) - Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, and Nevro Corp. …
Globus Medical to buy neurostim developer Nevro for $250M
1 day ago · Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its neuromodulation platforms for treating chronic pain. The all …
Globus Medical strengthens SCS market position with $250m Nevro …
1 day ago · Globus Medical, which has a market cap of $11.9bn, will buy all Nevro shares for $5.85 each, amounting to a total equity value of around $250m. The share purchase price …
Globus Medical to Acquire Nevro Corp. in All-Cash Transaction
5 days ago · Globus Medical and Nevro Preliminary Full-Year 2024 Revenue Outlook: On January 8, 2025, Globus Medical announced preliminary 2024 net sales of $2.52 billion, an increase of …
Globus Medical to Acquire Nevro Corp. in Strategic $250 Million …
Nevro’s preliminary 2024 revenue is estimated at $408 million to $409 million, while Globus expects 2024 net sales of $2.52 billion, a 60.6% increase over the prior year.
Globus to buy Nevro for $250M - MedTech Dive
6 days ago · Globus Medical plans to buy spinal cord stimulation company Nevro for about $250 million, the companies announced on Thursday. Globus will pay $5.85 per share in an all-cash …
Globus Medical to acquire Nevro for $250 million - Investing.com
6 days ago · The upcoming financial reporting will see Globus Medical release its full 2024 results and updated 2025 outlook on February 20, 2025, while Nevro will disclose its full-year 2024 …
Globus Medical to Acquire Nevro in $250 Million Deal to Expand C
5 days ago · Globus Medical (GMED, Financials) agreed to acquire Nevro Corp. (NVRO, Financials) in an all-cash transaction valued at approximately $250 million.Globus will buy all …
Globus Medical to Acquire Nevro Corp. to Expand Treatment
5 days ago · Globus Medical and Nevro Preliminary Full-Year 2024 Revenue Outlook: On January 8, 2025, Globus Medical announced preliminary 2024 net sales of $2.52 billion, an increase of …
Globus acquires Nevro for their spinal cord stimulation for $250M
5 days ago · Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, and Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering …
- Some results have been removed